These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 20594554)

  • 1. Decreased serum levels of thioredoxin in patients with coronary artery disease plus hyperhomocysteinemia is strongly associated with the disease severity.
    Wu Y; Yang L; Zhong L
    Atherosclerosis; 2010 Sep; 212(1):351-5. PubMed ID: 20594554
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High redox thioredoxin but low thioredoxin reductase activities in the serum of patients with rheumatoid arthritis.
    Lemarechal H; Allanore Y; Chenevier-Gobeaux C; Ekindjian OG; Kahan A; Borderie D
    Clin Chim Acta; 2006 May; 367(1-2):156-61. PubMed ID: 16458876
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Methylenetetrahydrofolate reductase gene C677T and A1298C polymorphisms, plasma homocysteine, folate, and vitamin B12 levels and the extent of coronary artery disease.
    Kölling K; Ndrepepa G; Koch W; Braun S; Mehilli J; Schömig A; Kastrati A
    Am J Cardiol; 2004 May; 93(10):1201-6. PubMed ID: 15135689
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The C677T mutation in methylenetetrahydrofolate reductase gene, plasma homocysteine concentration and the risk of coronary artery disease.
    Kadziela J; Janas J; Dzielińska Z; Szperl M; Gaździk D; Chotkowska E; Piotrowski W; Ruzyłło W
    Kardiol Pol; 2003 Jul; 59(7):17-26; discussion 26. PubMed ID: 14560345
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effect of oxidative stress-associated damage to the lung tissue caused by different body mass index in the rat models].
    Li XY; Zhang XJ; Zhao JH; Xu JY
    Zhonghua Jie He He Hu Xi Za Zhi; 2016 Dec; 39(12):958-961. PubMed ID: 27938548
    [No Abstract]   [Full Text] [Related]  

  • 6. Plasma homocysteine levels & 677C-->T methylenetetrahydrofolate reductase gene polymorphism in patients with coronary artery disease of different severity.
    Rassoul F; Richter V; Hentschel B; Geisel J; Herrmann W; Kuntze T
    Indian J Med Res; 2008 Feb; 127(2):154-8. PubMed ID: 18403793
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Body iron stores and coronary atherosclerosis assessed by coronary angiography.
    Auer J; Rammer M; Berent R; Weber T; Lassnig E; Eber B
    Nutr Metab Cardiovasc Dis; 2002 Oct; 12(5):285-90. PubMed ID: 12616808
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effects of hyperhomocysteinemia on the presence, extent, and severity of coronary artery disease.
    Bozkurt A; Toyaksi H; Acartürk E; Tuli A; Cayli M
    Jpn Heart J; 2003 May; 44(3):357-68. PubMed ID: 12825803
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of Diabetes on Homocysteine Levels and Its Relationship with Coronary Artery Disease: A Single-Centre Cohort Study.
    Schaffer A; Verdoia M; Barbieri L; Cassetti E; Suryapranata H; De Luca G
    Ann Nutr Metab; 2016; 68(3):180-8. PubMed ID: 26950830
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The association of plasma homocysteine, coronary risk factors and serum nitrite in patients with coronary artery disease, vascular syndrome x and healthy subjects.
    Soysal D; Savaş S; Susam I; Cevik C; Göldeli E; Sözmen E; Güneri S
    Anadolu Kardiyol Derg; 2003 Mar; 3(1):26-34, AXVIII-AXIX. PubMed ID: 12626307
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activity assays of mammalian thioredoxin and thioredoxin reductase: fluorescent disulfide substrates, mechanisms, and use with tissue samples.
    Montano SJ; Lu J; Gustafsson TN; Holmgren A
    Anal Biochem; 2014 Mar; 449():139-46. PubMed ID: 24374250
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Homocysteine level and coronary artery disease.
    Kazemi MB; Eshraghian K; Omrani GR; Lankarani KB; Hosseini E
    Angiology; 2006; 57(1):9-14. PubMed ID: 16444451
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combined effect of hyperhomocysteinemia and smoking on the severity of coronary artery disease in young adults ≤ 35 years of age: a hospital-based observational study.
    Sun J; Han W; Wu S; Jia S; Yan Z; Guo Y; Zhao Y; Zhou Y; Liu X
    BMC Cardiovasc Disord; 2021 Oct; 21(1):484. PubMed ID: 34627150
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hyperhomocysteinemia is a risk factor for coronary arteriosclerosis in Japanese patients with type 2 diabetes.
    Okada E; Oida K; Tada H; Asazuma K; Eguchi K; Tohda G; Kosaka S; Takahashi S; Miyamori I
    Diabetes Care; 1999 Mar; 22(3):484-90. PubMed ID: 10097933
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Homocysteine, vitamin B12 and folate levels in premature coronary artery disease.
    Sadeghian S; Fallahi F; Salarifar M; Davoodi G; Mahmoodian M; Fallah N; Darvish S; Karimi A;
    BMC Cardiovasc Disord; 2006 Sep; 6():38. PubMed ID: 17002799
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cysteine is a better predictor of coronary artery disease than conventional homocysteine in high-risk subjects under preventive medication.
    Lima A; Ferin R; Fontes A; Santos E; Martins D; Baptista J; Pavão ML
    Nutr Metab Cardiovasc Dis; 2020 Jul; 30(8):1281-1288. PubMed ID: 32522470
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma homocysteine level and the angiographic extent of coronary artery disease.
    Bozkurt E; Keles S; Acikel M; Islek M; Ateşal S
    Angiology; 2004; 55(3):265-70. PubMed ID: 15156259
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolic syndrome and homocysteine level as predictors of the severity of coronary artery disease in patients with carotid stenosis.
    Hsieh MJ; Chen CC; Lee TH; Lee CH; Wen MS; Lin FC; Hsieh IC; Wu D
    Am J Med Sci; 2009 Dec; 338(6):447-52. PubMed ID: 19794302
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma homocysteine levels and the left ventricular systolic function in coronary artery disease patients.
    Bokhari SW; Bokhari ZW; Zell JA; Lee DW; Faxon DP
    Coron Artery Dis; 2005 May; 16(3):153-61. PubMed ID: 15818084
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A thioredoxin reductase and/or thioredoxin system-based mechanism for antioxidant effects of ambroxol.
    Huang J; Xu J; Tian L; Zhong L
    Biochimie; 2014 Feb; 97():92-103. PubMed ID: 24103200
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.